Regeneron Pharmaceuticals (REGN) Non Operating Interest Expenses (2009 - 2026)
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | 582,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.00 Mn |
| Mar 31, 2026 | 12.90 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Sep 30, 2025 | 19.30 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | 8.70 Mn |
| Dec 31, 2024 | 10.50 Mn |
| Sep 30, 2024 | 13.80 Mn |
| Jun 30, 2024 | 14.80 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Dec 31, 2023 | 18.30 Mn |
| Sep 30, 2023 | 17.80 Mn |
| Jun 30, 2023 | 18.90 Mn |
| Mar 31, 2023 | 18.00 Mn |
| Dec 31, 2022 | 17.40 Mn |
| Sep 30, 2022 | 15.30 Mn |
| Jun 30, 2022 | 13.10 Mn |
| Mar 31, 2022 | 13.60 Mn |
| Dec 31, 2021 | 14.10 Mn |
| Sep 30, 2021 | 14.20 Mn |